The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield ...

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk ...

“It is a progressive condition eventually leading to kidney failure requiring dialysis or ... including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide ...

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...

Study finds yet another use for popular diabetes and obesity drugs - Several new uses have been found for the drugs ...

including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza). The results showed that compared to placebo, GLP-1 receptor agonists reduced the risk of ...

Giovanni E. Ferreira, University of Sydney and Christina Abdel Shaheed, University of Sydney The drug semaglutide, commonly ...

The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19, researchers found.

November is Diabetes and Kidney Disease Awareness month, and a great time to find out how you can protect yourself from a ...